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The existence of a relationship between cancer 
and heredity has been recognized for years, but only 
recently has emerging knowledge in this area enabled 
physicians to detect and treat cancer earlier in af-
fected individuals and to prevent its occurrence in 
others. 
The genetics of human cancer can be divided 
into three categories: first, cancers inherited by direct 
gene transmission; second, familial disorders not 
characterized by malignant disease themselves but 
which predispose to an increased likelihood of devel-
oping cancer; third, cancers of one or more types 
occurring with an increased incidence within a family 
but with a mode of genetic transmission that may not 
be clear. 
A relatively small proportion of cancers are in-
herited as a result of direct single gene transmission . 
One example is retinoblastoma, a highly malignant 
tumor of the eye which presents in early childhood, 
and which occurs in two different forms. The less 
common familial form of the disease is usually trans-
mitted as a highly penetrant dominant trait, with af-
fected individuals often having bilateral involvement 
and a somewhat earlier age of onset. The more com-
mon form is characteristically sporadic, with affected 
individuals having unilateral disease and a later age 
of onset.' As more affected persons will now reach 
adulthood and reproduce because of improved treat-
ment, clarification of the mode of inheritance is 
mandatory to allow proper genetic counseling. 
Multiple endocrine adenomatosis type II or 
Sipple syndrome consists of the association of medul-
lary carcinoma of the thyroid, pheochromocytoma, 
and parathyroid hyperplasia. This disorder appears 
to be inherited as an autosomal dominant but with 
incomplete penetrance. As with many inherited can-
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cers, there is an increased incidence of bilateral organ 
involvement. Clinically, the patient may present with 
evidence of carcinoma in only one system; for ex-
ample, medullary carcinoma of the thyroid may be 
present without a palpable thyroid nodule. However, 
appropriate testing may show occult disease in the 
other organs. An elevated serum calcitonin level may 
suggest an occult cancer in predisposed individuals2; 
therefore, diagnosis of any of the features of this 
unusual syndrome should lead to careful exclusion of 
the others, as well as to a search among close relatives 
for additional, possibly presymptomatic, cases. 
Familial polyposis coli is an autosomal domi-
nant disorder in which adenomatous polyps may be 
so numerous that they actually carpet the entire colon 
and rectum; Gardner syndrome is a distinct variant 
that includes associated sebaceous cysts and osteo-
mas of bone. Early recognition of these disorders is 
critical since virtually I 00% of affected persons will 
develop carcinoma of the colon by age 50 unless a 
prophylactic colectomy is performed.3 A number of 
oncologists now recommend total colectomy as soon 
as the disorder is discovered in childhood unless it is 
possible to follow the affected child with regular sig-
moidoscopies and barium enemas. The management 
of these families can be extremely d ifficult since it is 
essential both to stress the importance of regular 
examination and to avoid contributing to an obses-
sive cancer phobia. 
Neurofibromatosis is an a utosomal dominant 
disorder characterized by cafe au lait spots and mul-
tiple neurofibromas. The neurofibromas show a sar-
comatous degeneration in about I 0% of patients, and 
there is an increased risk of gliomas of the brain or 
optic nerve, meningiomas, acoustic neuromas, and 
pheochromocytomas. 
Xeroderma pigmentosa is a rare disorder mani-
fested by sun sensitivity and the development of 
freckles on sun-exposed areas which then become dry 
and scaly. Basa l cell and squamous cell carcinomas of 
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the skin later develop, and even if they are arrested, 
affected individuals have an increased risk of mela- Neoplasms with Possible Familial Occurrence 
noma. 1 Xeroderma pigmentosa is transmitted as an 
autosomal recessive trait. The defect has been shown 
to be a specific deficiency in one of the several en-
zymes normally required to repair ultraviolet radia-
tion damage to the DNA of epidermal cells.4 When 
the precipitating causes of the problem are appreci-
ated, the physician can teach affected individuals to 
protect themselves from the carcinogenic effects of 
ultraviolet radiation without undue disruption of a 
normal lifestyle.5 
Immune deficiency disorders are associated with 
an increased incidence of cancer, particularly lym-
phoma. The prime examples are the recessively inher-
ited syndromes such as X-linked agammaglobuli-
nemia, ataxia telangiectasia, and Wiskott-Aldrich 
syndrome. Individually, each of these recessive syn-
dromes is rare, and in the aggregate, affected homo-
zygotes (or hemizygotes if the trait is X-linked) con-
stitute only a small proportion of all patients who 
develop cancer. However, there is increasing evidence 
that heterozygous carriers of at least some of these 
recessive genes may also be predisposed to cancer. 
Carriers of rare recessive genes are, of course, much 
more numerous in the general population than are 
affected homozygotes; in fact, the rarer the recessive 
trait, the greater the relative frequency of hetero-
zygous carriers in the population in comparison with 
affected homozygotes. Therefore, a small effect of 
cancer risk in heterozygotes could have much greater 
public health significance than would a major effect 
in homozygotes. Swift6 has provided convincing evi-
dence that heterozygous carriers of the genes for 
ataxia telangiectasia and Fanconi anemia have a 
three- to fourfold increased risk of developing cancer; 
he has estimated that at least 3% of all cancers arise in 
individuals who are heterozygous for one or the other 
of these two genes alone. At present, no laboratory 
test is available to identify carriers. 
Detecting an increased familial risk of cancer 
and following the involved family members for evi-
dence of developing neoplasia is an important activ-
ity for practicing physicians. The cancers may be 
always of the same organ, that is, a site-specific tumor 
may occur in familial aggregations, or they may be of 
multiple varied organs. The Table lists the site-spe-
cific malignant neoplasms with possible familial oc-
currence.7 
There is considerable heterogeneity in the ge-
netics of certain cancers, especially breast cancer. 
Breast 
Colon 
Stomach 
Prostate 
Endometrium 
Hodgkin disease 
Waldenstrom disease 
Multiple myeloma 
Leukemia 
Lymphoma 
Hepatocellular tumors 
Testicular tumors 
Neuroblastoma 
Wilmstumor 
Burkitt lymphoma 
Bronchogenic carcinoma 
Ovarian carcinoma 
Studies8 - 10 have helped elucidate some of the risk 
factors. It is important to know whether the disease 
has occurred in two or more female first-degree re-
latives, whether the disease was pre- or post-meno-
pausal in onset, and whether it was bilateral. In 
the premenopausal age group, the relative risk of 
breast cancer among family members of an affected 
individual is approximately three times that of con-
trols, whereas in the postmenopausal age group, the 
risk is only slightly greater than that of controls. 
Relatives of women with bilateral disease have a five-
fold risk compared to controls. The relatives of 
women with premenopausal and bilateral disease 
have a relative risk of developing breast cancer that is 
almost nine times greater than that of controls, while 
the relatives of patients with postmenopausal bilat-
eral disease have a risk that is four times greater. The 
risk to other family members also depends upon the 
relationship of prior affected persons to the proband. 
For example, if prior disease involved a proband's 
mother, the proband's sisters will have a 30% in-
cidence of cancer in the 20-to 29-year age group, a 
risk 47 times greater than that of the general popu-
lation . Clearly, these facts imply a genetic factor in 
breast cancer which appears most consistent with 
polygenic inheritance of a predisposition. Physician 
recognition of and response to this inherited pre-
disposition is important particularly in the high-risk 
situation. In one such family, for example, bilateral 
reduction mammoplasty with implantation of a sub-
cutaneous prosthesis was recommended for a 19-
year-old girl whose two sisters, mother, and maternal 
grandmother had had early onset of breast cancer. 11 
The concept of "cancer families" has been 
broadened to include kindreds displaying familial oc-
currence of diverse neoplasms even of dissimilar cell 
types. 12 The cancer family has the following charac-
teristics: I) an increased occurrence of adenocarci-
noma primarily of colon and endometrium; 2) in-
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creased frequency of multiple primary malignant 
neoplasms; 3) early age of onset of cancer relative to 
the usual age of onset of that cancer in the general 
population; 4) vertical transmission of cancer consis-
tent with an autosomal dominant inheritance pattern. 
One such family has been described in Virginia. 13 
Environmental factors may also influence ex-
pression of the disease when there is a familial ten-
dency to cancer. Studies by Tokuhata have confirmed 
an increased incidence of cancer of the lung in rela-
tives of patients with lung cancer, and his data sug-
gest that the combined risk of cigarette smoking and 
the familial host factor increase the liability of devel-
oping lung cancer in a synergistic rather than additive 
manner. 1• 
The interrelationships between heredity and en-
vironment in the occurrence of cancer are complex 
and in many cases not completely characterized, but 
certain facts are clear. Specific cancers can be inher-
ited directly . Certain diseases that predispose to can-
cer are inherited, and specific cancers or specific ten-
dencies to develop a variety of cancers are inherited 
in families. Examples of each of these have been 
discussed. The long-range challenge to physicians is 
to recognize these situations and to study them thor-
oughly to further our understanding of the causes of 
cancer. More immediately, however, the alert physi-
cian who takes a detailed family history can recognize 
the increased risk of a particular malignancy and, by 
careful examination, testing, advice, and follow-up, 
can provide early treatment or even prevent the de-
velopment of a potentially fatal malignancy. 11 
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